Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia

Br J Haematol. 2004 Nov;127(3):360-1; author reply 361-2. doi: 10.1111/j.1365-2141.2004.05195.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiomyopathies / etiology
  • Cardiomyopathies / metabolism
  • Cardiomyopathies / prevention & control*
  • Deferiprone
  • Humans
  • Iron Chelating Agents / administration & dosage*
  • Magnetic Resonance Imaging*
  • Myocardium / metabolism
  • Pyridones / administration & dosage*
  • Thalassemia / complications
  • Thalassemia / metabolism

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone